Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in
hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean
population.